Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P H Wilding

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|July 31, 2002
Neuropeptides and appetite controlJ P H Wilding
International Journal of Clinical Practice|February 20, 2014
The importance of weight management in type 2 diabetes mellitusJ P H Wilding
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|February 24, 2007
Treatment strategies for obesityJ P H Wilding
Diabetes, Obesity & Metabolism|March 27, 2012
PPAR agonists for the treatment of cardiovascular disease in patients with diabetesJ P H Wilding
Clinical Obesity|April 25, 2018
Beyond lifestyle interventions: exploring the potential of anti-obesity medications in the UKJ P H Wilding
Diabetic Medicine : a Journal of the British Diabetic Association|August 30, 2007
The importance of free fatty acids in the development of Type 2 diabetesJ P H Wilding
Brain Research|July 13, 2004
Reduced ventromedial hypothalamic neuronal nitric oxide synthase and increased sensitivity to NOS inhibition in dietary obese rats: further evidence of a role for nitric oxide in the regulation of energy balanceC J Sadler, J P H Wilding
Diabetes, Obesity & Metabolism|January 4, 2007
Effects of S 15511, a therapeutic metabolite of the insulin-sensitizing agent S 15261, in the Zucker Diabetic Fatty ratL C Pickavance, J P H Wilding
Diabetic Medicine : a Journal of the British Diabetic Association|November 4, 2015
Role of incretin-based therapies and sodium-glucose co-transporter-2 inhibitors as adjuncts to insulin therapy in Type 2 diabetes, with special reference to IDegLiraJ P H Wilding, S C Bain
Diabetic Medicine : a Journal of the British Diabetic Association|June 11, 2011
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula performs worse than the Modification of Diet in Renal Disease (MDRD) equation in estimating glomerular filtration rate in Type 2 diabetic chronic kidney diseaseS Nair, K J Hardy, J P H Wilding
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Diabetic Medicine : a Journal of the British Diabetic Association|July 31, 2002
Neuropeptides and appetite controlJ P H Wilding
International Journal of Clinical Practice|February 20, 2014
The importance of weight management in type 2 diabetes mellitusJ P H Wilding
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|February 24, 2007
Treatment strategies for obesityJ P H Wilding
Diabetes, Obesity & Metabolism|March 27, 2012
PPAR agonists for the treatment of cardiovascular disease in patients with diabetesJ P H Wilding
Clinical Obesity|April 25, 2018
Beyond lifestyle interventions: exploring the potential of anti-obesity medications in the UKJ P H Wilding
Diabetic Medicine : a Journal of the British Diabetic Association|August 30, 2007
The importance of free fatty acids in the development of Type 2 diabetesJ P H Wilding
Brain Research|July 13, 2004
Reduced ventromedial hypothalamic neuronal nitric oxide synthase and increased sensitivity to NOS inhibition in dietary obese rats: further evidence of a role for nitric oxide in the regulation of energy balanceC J Sadler, J P H Wilding
Diabetes, Obesity & Metabolism|January 4, 2007
Effects of S 15511, a therapeutic metabolite of the insulin-sensitizing agent S 15261, in the Zucker Diabetic Fatty ratL C Pickavance, J P H Wilding
Diabetic Medicine : a Journal of the British Diabetic Association|November 4, 2015
Role of incretin-based therapies and sodium-glucose co-transporter-2 inhibitors as adjuncts to insulin therapy in Type 2 diabetes, with special reference to IDegLiraJ P H Wilding, S C Bain
Diabetic Medicine : a Journal of the British Diabetic Association|June 11, 2011
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula performs worse than the Modification of Diet in Renal Disease (MDRD) equation in estimating glomerular filtration rate in Type 2 diabetic chronic kidney diseaseS Nair, K J Hardy, J P H Wilding
Pageof 6